Central Nervous System

Our research and development division is committed to discovering new products that will make a difference in people's lives.

 

As well as producing a therapy for treating epilepsy, Sanofi medicines for central nervous system disorders range from a treatment for Multiple Sclerosis and hypnotics for treating insomnia to compounds for stabilising the extreme mood swings associated with bipolar disorder. We also have a anti-psychotic for controlling the symptoms of schizophrenia.

• Epilim® (sodium valproate)
  
  

• Solian® (amisulpride)

• Stilnoct® (zolpidem tartrate)